1. Home
  2. ISDR vs PMN Comparison

ISDR vs PMN Comparison

Compare ISDR & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISDR
  • PMN
  • Stock Information
  • Founded
  • ISDR 1988
  • PMN 2004
  • Country
  • ISDR United States
  • PMN Canada
  • Employees
  • ISDR N/A
  • PMN N/A
  • Industry
  • ISDR Publishing
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • ISDR Consumer Discretionary
  • PMN Health Care
  • Exchange
  • ISDR Nasdaq
  • PMN Nasdaq
  • Market Cap
  • ISDR 37.2M
  • PMN 32.3M
  • IPO Year
  • ISDR N/A
  • PMN N/A
  • Fundamental
  • Price
  • ISDR $9.14
  • PMN $0.92
  • Analyst Decision
  • ISDR
  • PMN
  • Analyst Count
  • ISDR 0
  • PMN 0
  • Target Price
  • ISDR N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • ISDR 6.3K
  • PMN 80.8K
  • Earning Date
  • ISDR 11-07-2024
  • PMN 12-31-2024
  • Dividend Yield
  • ISDR N/A
  • PMN N/A
  • EPS Growth
  • ISDR N/A
  • PMN N/A
  • EPS
  • ISDR N/A
  • PMN N/A
  • Revenue
  • ISDR $29,141,000.00
  • PMN N/A
  • Revenue This Year
  • ISDR N/A
  • PMN N/A
  • Revenue Next Year
  • ISDR N/A
  • PMN N/A
  • P/E Ratio
  • ISDR N/A
  • PMN N/A
  • Revenue Growth
  • ISDR N/A
  • PMN N/A
  • 52 Week Low
  • ISDR $7.61
  • PMN $0.87
  • 52 Week High
  • ISDR $19.03
  • PMN $3.10
  • Technical
  • Relative Strength Index (RSI)
  • ISDR 41.20
  • PMN 45.09
  • Support Level
  • ISDR $8.62
  • PMN $0.87
  • Resistance Level
  • ISDR $9.82
  • PMN $1.00
  • Average True Range (ATR)
  • ISDR 0.30
  • PMN 0.07
  • MACD
  • ISDR -0.05
  • PMN -0.00
  • Stochastic Oscillator
  • ISDR 52.14
  • PMN 31.31

About ISDR Issuer Direct Corporation

Issuer Direct Corp is a communications and compliance company. It focuses on the needs of corporate issuers. It provides disclosure management solutions, shareholder communications tools, and cloud-based compliance technologies. Its customers include public and private companies, mutual funds, law firms, brokerage firms, investment banks, individuals, and other institutions. Its products include PR solutions, IR solutions, Compliance, and Event management software.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: